Bylvay 600 (Odevixibat Capsule) 600mcg

Bylvay 600mcg (Odevixibat) capsules provide bile acid modulation for managing pruritus in progressive familial intrahepatic cholestasis. This 600mcg strength therapy is designed for convenient oral administration. Ideal for patients seeking targeted symptom relief in cholestatic liver conditions.

Strength

600mcg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Albireo AB

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bylvay 600mcg capsules are used to treat pruritus (itching) associated with progressive familial intrahepatic cholestasis (PFIC) in adults and children aged 3 months and older. It may also be prescribed for other cholestatic liver conditions causing persistent itching. This medication works by reducing bile acid levels in the bloodstream.

Side Effects

Users typically experience reduced itching within the first weeks of starting Bylvay 600mcg. Some may notice improved sleep quality and daily comfort as pruritus symptoms diminish. Individual responses vary, with some patients reporting gradual symptom relief over time.

Precautions & Warnings

Store Bylvay 600mcg capsules at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications and supplements you're taking before starting this treatment. Regular monitoring may be recommended during therapy.

Avoid Interactions

Bylvay 600mcg may interact with medications that affect bile acid metabolism or transport. Caution is advised when combining with other drugs processed by the liver. Alcohol consumption may alter liver enzyme activity, potentially affecting treatment outcomes. Always consult a healthcare professional before mixing medications.

Frequently Asked Questions

Bylvay 600mcg is used to treat persistent itching caused by certain liver conditions like progressive familial intrahepatic cholestasis (PFIC).

Some patients notice reduced itching within weeks, but individual response times may vary.

Consult your healthcare provider before combining Bylvay with other drugs to avoid potential interactions.

Bylvay is approved for children aged 3 months and older under medical supervision.

Take the missed dose as soon as you remember, but skip it if it’s almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.